Related Experiment Video
Updated: Jul 27, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
[Significance of the uPA/uPAR system for development of arteriosclerosis and restenosis]
1Franz-Volhard-Klinik am Max-Delbrück-Zentrum für Molekulare Medizin Wiltbergstr. 50 13125 Berlin, Germany. kusch@fvk-berlin.de
Insights
Arteriosclerosis and restenosis involve vascular smooth muscle cell migration and proliferation. The urokinase plasminogen activator (uPA)/uPAR system drives these processes, offering therapeutic targets.
Area of Science:
- Cardiovascular Biology
- Cellular Signaling
- Extracellular Matrix Remodeling
Context:
- Arteriosclerosis and restenosis are significant clinical challenges.
- Vascular smooth muscle cell (VSMC) migration and proliferation are key pathomechanisms.
- Cell migration involves complex processes including chemotaxis and matrix remodeling.
Purpose:
- To elucidate the role of the urokinase plasminogen activator (uPA)/uPAR system in VSMC migration and proliferation.
- To highlight the multifunctional nature of uPA/uPAR in regulating cellular processes.
- To identify the uPA/uPAR system as a potential therapeutic target for preventing vascular diseases.
Summary:
- Increased expression of urokinase plasminogen activator (uPA) and its receptor (uPAR) is observed in migrating VSMCs.
- The uPA/uPAR system mediates extracellular proteolysis, matrix remodeling, and cell migration.
- This system influences various signal transduction pathways, impacting cell migration and proliferation, often in conjunction with integrins and other signaling molecules.
Impact:
- Understanding the uPA/uPAR system's role provides insights into arteriosclerosis and restenosis.
- Targeting the uPA/uPAR system or its pathways may lead to novel therapeutic strategies.
- This research guides the development of treatments to prevent vascular complications after interventions like angioplasty.
Abstract:
Arteriosclerosis and the development of restenosis still remain a significant clinical problem. Migration of vascular smooth muscle cells from the media to the intima and cell proliferation are the hallmarks of the underlying pathomechanisms. Cell migration requires chemotaxis, phenotypic changes of cells, cell adhesive and de-adhesive events and the coordinated remodeling of the extracellular matrix. One of the phenotypic changes induced in migrating cells is the increased expression of urokinase plasminogen activator (uPA) and of its specific receptor uPAR. They are polarized to the leading edge of migrating cells. Both uPA and uPAR are key mediators of extracellular proteolysis. They participate in extracellular matrix remodeling, activate cells and enable them to migrate and invade into different tissue layers. UPA/uPAR are multifunctional proteins influencing a great variety of signal transduction pathways ultimately culminating in the regulation of cell migration and proliferation. In addition to time- and space-confined proteolysis this powerful system can mediate chemotaxis, cell adhesion and gene expression, partly by interacting in concert with integrins, G proteins, or with yet unidentified coreceptors or adapter molecules. Interaction with the uPA/uPAR system or components of its specific signal transduction pathways may serve as a guide for the development of effective therapeutic strategies to prevent arteriosclerosis and restenosis after percutaneous arterial angioplastic interventions.
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Atherosclerosis I: Introduction
Atherosclerosis III: Management
Atherosclerosis IV: Nursing Management
Peripheral Artery Disease I: Introduction
Peripheral Artery Disease III: Interprofessional Care

